Developing affordable and accessible treatments for dengue through partnerships with institutions in the most affected countries

Founded: 2022

A global partnership led by institutions from dengue-endemic countries, the Dengue Alliance is advancing urgently needed pre-clinical research, testing the efficacy of repurposed drug candidates, and implementing clinical trials of the most promising potential dengue treatments. Alliance members also coordinate efforts to help overcome knowledge gaps, expedite clinical research and regulatory review, address unmet needs in diagnostics, mobilize resources, and share research knowledge openly.

Dengue, a climate-sensitive neglected tropical disease, is one of the top ten threats to global public health worldwide. Despite an estimated 390 million infections each year in more than 100 countries, there is no specific treatment available. More than 70% of the disease burden is estimated to be in Asia, with rapidly growing incidence in other parts of the world – in particular the Americas.

Alliance updates